{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T07:18:16Z","timestamp":1788160696903,"version":"build-2803163510"},"reference-count":76,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>Hip involvement is a common presentation of chronic inflammatory rheumatic diseases.\nIt profoundly affects patients\u2019 functional status and quality of life, reflecting a more severe\ndisease. As the hip joint disease progresses, it can lead to severe disability. Arthroplasty is the\nmost effective option for relieving pain and restoring function. Over the last few years, there has\nbeen a notable decrease in hip joint replacements, driven by satisfactory outcomes achieved with\nconservative strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>This review summarizes the current evidence regarding the effect of available biological treatments\non hip involvement in inflammatory rheumatic diseases. A narrative review was conducted\nusing the PubMed database to identify case reports, case series, and original articles published up\nto 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>TNF\u03b1 inhibitors are effective in relieving hip involvement symptoms, maintaining satisfactory\nhip function, and stabilizing radiographic hip damage in patients with inflammatory rheumatic\ndiseases. Tocilizumab seems to stop and reduce hip radiographic damage in patients with systemic\njuvenile idiopathic arthritis. IL-17\/IL-23 axis inhibitors are effective in relieving hip pain in patients\nwith spondyloarthritis, but their effect on hip structural damage remains unknown. Despite\nthese promising findings, data regarding hip involvement remain scarce and limited to observational\nstudies and case series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115733971396868251024105345","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:22:53Z","timestamp":1769145773000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Biological Treatment on Hip Involvement in Inflammatory Rheumatic Diseases"],"prefix":"10.2174","volume":"22","author":[{"given":"Kaouther","family":"Maatallah","sequence":"first","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maissa","family":"Abbes","sequence":"additional","affiliation":[{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Rheumatology Department, Rabta Hospital, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobna","family":"Kharrat","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorra","family":"Ben Nessib","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Majdoub","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanene Lassoued","family":"Ferjani","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhia","family":"Kaffel","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hamdi","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Kassab Orthopedics Institute, Ksar Sa\u00efd, Tunis, Tunisia"},{"name":"Faculty of medicine of Tunis, University Tunis el Manar, Tunis, Tunisia"},{"name":"Research Unit UR17SP04, 2010, Ksar Said 2010, Tunis, Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10067-013-2278-3","volume":"32","author":"Guan M.","year":"2013","unstructured":"Guan M.; Wang J.; Zhao L.; Xiao J.; Li Z.; Shi Z.; Management of hip involvement in ankylosing spondylitis. Clin Rheumatol  2013,32(8),1115-1120","journal-title":"Clin Rheumatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/BOR.0b013e3283620e04","volume":"25","author":"Cruyssen V.B.","year":"2013","unstructured":"Cruyssen V.B.; Vastesaeger N.; Collantes-Est\u00e9vez E.; Hip disease in ankylosing spondylitis. Curr Opin Rheumatol  2013,25(4),448-454","journal-title":"Curr Opin Rheumatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00296-021-04931-2","volume":"42","author":"Zhao S.S.","year":"2022","unstructured":"Zhao S.S.; Nikiphorou E.; Young A.; Kiely P.D.W.; Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status\u2014results from the early rheumatoid arthritis study. Rheumatol Int  2022,42(4),621-629","journal-title":"Rheumatol Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s00590-023-03525-x","volume":"33","author":"Barik S.","year":"2023","unstructured":"Barik S.; Jain A.; Chanakya P.V.; Raj V.; Goyal T.; What has changed in total hip arthroplasty in patients of juvenile idiopathic arthritis since 2000? A systematic review and pooled data analysis. Eur J Orthop Surg Traumatol  2023,33(7),2737-2748","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"15097","DOI":"10.1111\/1756-185X.15097","volume":"27","author":"Shirasugi I.","year":"2024","unstructured":"Shirasugi I.; Onishi A.; Nishimura K.; Association of large joint involvement at the start of biological disease\u2010modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study. Int J Rheum Dis  2024,27(3),15097","journal-title":"Int J Rheum Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5001\/omj.2012.109","volume":"27","author":"Hamdi W.","year":"2012","unstructured":"Hamdi W.; Azzouz D.; Ghannouchi M.M.; Health-related quality of life assessment on 100 Tunisian patients with ankylosing spondylitis using the SF 36 survey. East Mediterr Health J  2012,27(6),455-460","journal-title":"East Mediterr Health J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10067-023-06789-0","volume":"43","author":"Guo S.","year":"2024","unstructured":"Guo S.; Zhang L.; Man S.; Association of radiological severity of hip involvement with clinical characteristics and sagittal spinopelvic balance in patients with ankylosing spondylitis. Clin Rheumatol  2024,43(1),233-240","journal-title":"Clin Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jos.2023.06.012","volume":"29","author":"Ido H.","year":"2024","unstructured":"Ido H.; Osawa Y.; Takegami Y.; Sacroiliac joint fusion in patients with ankylosing spondylitis is associated with hip involvement. J Orthop Sci  2024,29(4),939-944","journal-title":"J Orthop Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/art.21907","volume":"54","author":"Appel H.","year":"2006","unstructured":"Appel H.; Kuhne M.; Spiekermann S.; Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone-cartilage interface and subchondral bone marrow. Arthritis Rheum  2006,54(6),1805-1813","journal-title":"Arthritis Rheum"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1097\/CM9.0000000000001743","volume":"134","author":"Rocha F.A.C.","year":"2021","unstructured":"Rocha F.A.C.; Deodhar A.; Coxitis in axial spondyloarthritis: The unmeasured, yet functionally most important, radiographic progression. Chin Med J  2021,134(21),2550-2552","journal-title":"Chin Med J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbspin.2014.08.003","volume":"82","author":"Wendling D.","year":"2015","unstructured":"Wendling D.; Guillot X.; Prati C.; The IL-23\/Th 17 pathway in spondyloarthritis: The royal road? Joint Bone Spine  2015,82(1),1-4","journal-title":"Joint Bone Spine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.3390\/ijms21176401","volume":"21","author":"Tsukazaki H.","year":"2020","unstructured":"Tsukazaki H.; Kaito T.; The role of the IL-23\/IL-17 pathway in the pathogenesis of spondyloarthritis. Int J Mol Sci  2020,21(17),6401","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/annrheumdis-2013-203963","volume":"73","author":"Nystad T.W.","year":"2014","unstructured":"Nystad T.W.; Furnes O.; Havelin L.I.; Skredderstuen A.K.; Lie S.A.; Fevang B.T.S.; Hip replacement surgery in patients with ankylosing spondylitis. Ann Rheum Dis  2014,73(6),1194-1197","journal-title":"Ann Rheum Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/annrheumdis-2017-212424","volume":"77","author":"Cordtz R.L.","year":"2018","unstructured":"Cordtz R.L.; Hawley S.; Prieto-Alhambra D.; Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: An interrupted time-series analysis using nationwide Danish healthcare registers. Ann Rheum Dis  2018,77(5),684-689","journal-title":"Ann Rheum Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10067-021-05683-x","volume":"40","author":"Maatallah K.","year":"2021","unstructured":"Maatallah K.; Ben Nessib D.; Hamdi W.; Comment on \u201cTumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis\u2014time to reconsider treatment guidelines? A case series and review of literature\u201d. Clin Rheumatol  2021,40(5),2109-2110","journal-title":"Clin Rheumatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molimm.2013.07.016","volume":"57","author":"Hreggvidsdottir H.S.","year":"2014","unstructured":"Hreggvidsdottir H.S.; Noordenbos T.; Baeten D.L.; Inflammatory pathways in spondyloarthritis. Mol Immunol  2014,57(1),28-37","journal-title":"Mol Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13933","volume":"1442","author":"Lata M.","year":"2019","unstructured":"Lata M.; Hettinghouse A.S.; Liu C.; Targeting tumor necrosis factor receptors in ankylosing spondylitis. Ann N Y Acad Sci  2019,1442(1),5-16","journal-title":"Ann N Y Acad Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/03009740802409504","volume":"38","author":"Chen W.S.","year":"2009","unstructured":"Chen W.S.; Chen C.H.; Lin K.C.; Immunohistological features of hip synovitis in ankylosing spondylitis with advanced hip involvement. Scand J Rheumatol  2009,38(2),154-155","journal-title":"Scand J Rheumatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186:AID-ANR25>3.0.CO;2-B","volume":"44","author":"Baeten D.","year":"2001","unstructured":"Baeten D.; Kruithof E.; Van den Bosch F.; Immunomodulatory effects of anti-tumor necrosis factor? therapy on synovium in spondylarthropathy: Histologic findings in eight patients from an open-label pilot study. Arthritis Rheum  2001,44(1),186-195","journal-title":"Arthritis Rheum"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"105111","DOI":"10.1016\/j.jbspin.2020.105111","volume":"88","author":"Konsta M.","year":"2021","unstructured":"Konsta M.; Sakellariou G.T.; Rusman T.; Sfikakis P.P.; Iliopoulos A.; van der Horst-Bruinsma I.E.; Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels. Joint Bone Spine  2021,88(3),105111","journal-title":"Joint Bone Spine"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jbspin.2019.04.006","volume":"87","author":"Aouad K.","year":"2020","unstructured":"Aouad K.; Ziade N.; Baraliakos X.; Structural progression in axial spondyloarthritis. Joint Bone Spine  2020,87(2),131-136","journal-title":"Joint Bone Spine"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/1744666X.2016.1117941","volume":"12","author":"Caso F.","year":"2016","unstructured":"Caso F.; Lubrano E.; Del Puente A.; Progress in understanding and utilizing TNF-\u03b1 inhibition for the treatment of psoriatic arthritis. Expert Rev Clin Immunol  2016,12(3),315-331","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jbspin.2011.03.023","volume":"78","author":"Wang D.","year":"2011","unstructured":"Wang D.; Ma L.; Wu D.; Efficacy of etanercept in ankylosing spondylitis hip lesions. Joint Bone Spine  2011,78(5),531-532","journal-title":"Joint Bone Spine"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00296-011-1844-8","volume":"32","author":"Lian F.","year":"2012","unstructured":"Lian F.; Yang X.; Liang L.; Treatment efficacy of etanercept and MTX combination therapy for ankylosing spondylitis hip joint lesion in Chinese population. Rheumatol Int  2012,32(6),1663-1667","journal-title":"Rheumatol Int"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5371\/hp.2013.25.2.135","volume":"25","author":"Kim Y.C.","year":"2013","unstructured":"Kim Y.C.; Moon S.W.; Etanercept treatment in ankylosing spondylitis hip lesions. Hip Pelvis  2013,25(2),135-140","journal-title":"Hip Pelvis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/0394632016656013","volume":"29","author":"Li J.","year":"2016","unstructured":"Li J.; Wang X.; Han Z.; Dose reduction of recombinant human tumor necrosis factor inhibitors (etanercept) can be effective in ankylosing spondylitis patients with synovitis of the hip in a Chinese population. Int J Immunopathol Pharmacol  2016,29(3),510-515","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10067-019-04466-9","volume":"38","author":"Huang Z.X.","year":"2019","unstructured":"Huang Z.X.; Deng W.M.; Guo X.; Clinical and MRI response to dose reduction of an etanercept-biosimilar for hip arthritis in patients with ankylosing spondylitis: An observational, retrospective cohort study. Clin Rheumatol  2019,38(6),1595-1604","journal-title":"Clin Rheumatol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10067-013-2263-x","volume":"32","author":"Konsta M.","year":"2013","unstructured":"Konsta M.; Sfikakis P.P.; Bournia V.K.; Karras D.; Iliopoulos A.; Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis. Clin Rheumatol  2013,32(8),1229-1232","journal-title":"Clin Rheumatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3899\/jrheum.161401","volume":"44","author":"Song R.","year":"2017","unstructured":"Song R.; Chung S.W.; Lee S.H.; Radiographic evidence of hip joint recovery in patients with ankylosing spondylitis after treatment with anti-tumor necrosis factor agents: A case series. J Rheumatol  2017,44(11),1759-1760","journal-title":"J Rheumatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"106927","DOI":"10.1016\/j.intimp.2020.106927","volume":"88","author":"Mahmoud I.","year":"2020","unstructured":"Mahmoud I.; Maatallah K.; Ben Nessib D.; Long term inhibition of hip joint damage under tumor necrosis factor-alpha inhibitors in spondyloarthritis. Int Immunopharmacol  2020,88,106927","journal-title":"Int Immunopharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10067-020-05519-0","volume":"40","author":"Rocha F.A.C.","year":"2021","unstructured":"Rocha F.A.C.; Pinto A.C.M.D.; Lopes J.R.; Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature. Clin Rheumatol  2021,40(5),1881-1887","journal-title":"Clin Rheumatol"},{"key":"ref=32","first-page":"303","volume":"9","author":"Maatallah K.","year":"2018","unstructured":"Maatallah K.; Mahmoud I.; Belghali S.; Reparative radiological changes of hip joint after TNF inhibitors in ankylosing spondylitis. Caspian J Intern Med  2018,9(3),303-305","journal-title":"Caspian J Intern Med"},{"key":"ref=33","first-page":"342","volume":"50","author":"Konsta M.","year":"2023","unstructured":"Konsta M.; Nurmohamed M.T.; Iliopoulos A.; Prevalence and radiographic progression of hip involvement in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors. J Rheumatol  2023,50(3),342-350","journal-title":"J Rheumatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/rheumatology\/key382","volume":"58","author":"Wink F.","year":"2019","unstructured":"Wink F.; Arends S.; Maas F.; High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-\u03b1 blocking therapy in ankylosing spondylitis. Rheumatology  2019,58(6),1040-1046","journal-title":"Rheumatology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10067-021-05628-4","volume":"40","author":"Huang Z.X.","year":"2021","unstructured":"Huang Z.X.; Deng W.M.; Zheng S.L.; Guo X.; Zeng S.Q.; Li T.W.; Magnetic resonance imaging in ankylosing spondylitis: Reduction of active sacroiliitis and hip arthritis during treatment with an adalimumab biosimilar. Clin Rheumatol  2021,40(5),2099-2101","journal-title":"Clin Rheumatol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3899\/jrheum.200453","volume":"48","author":"Stovall R.","year":"2021","unstructured":"Stovall R.; Peloquin C.; Felson D.; Neogi T.; Dubreuil M.; Relation of NSAIDs, DMARDs, and TNF inhibitors for ankylosing spondylitis and psoriatic arthritis to risk of total hip and knee arthroplasty. J Rheumatol  2021,48(7),1007-1013","journal-title":"J Rheumatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1478-6354-13-S1-S4","volume":"13","author":"Schett G.","year":"2011","unstructured":"Schett G.; Coates L.C.; Ash Z.R.; Finzel S.; Conaghan P.G.; Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther  2011,13(S1),S4","journal-title":"Arthritis Res Ther"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/ard.61.4.311","volume":"61","author":"den Broeder A.A.","year":"2002","unstructured":"den Broeder A.A.; Joosten L A B.; Saxne T.; Long term anti-tumour necrosis factor \u03b1 monotherapy in rheumatoid arthritis: Effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis  2002,61(4),311-318","journal-title":"Ann Rheum Dis"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1080\/14397595.2017.1280113","volume":"27","author":"Kanbe K.","year":"2017","unstructured":"Kanbe K.; Oh K.; Chiba J.; Inoue Y.; Taguchi M.; Yabuki A.; Efficacy of golimumab for preventing large joint destruction in patients with rheumatoid arthritis as determined by the ARASHI score. Mod Rheumatol  2017,27(6),938-945","journal-title":"Mod Rheumatol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10067-008-1076-9","volume":"28","author":"Seki E.","year":"2009","unstructured":"Seki E.; Matsushita I.; Sugiyama E.; Radiographic progression in weight-bearing joints of patients with rheumatoid arthritis after TNF-blocking therapies. Clin Rheumatol  2009,28(4),453-460","journal-title":"Clin Rheumatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/14397595.2015.1109785","volume":"26","author":"Nakajima A.","year":"2016","unstructured":"Nakajima A.; Aoki Y.; Sonobe M.; Radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying anti-rheumatic drugs. Mod Rheumatol  2016,26(4),517-521","journal-title":"Mod Rheumatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/14397595.2016.1227235","volume":"27","author":"Matsushita I.","year":"2017","unstructured":"Matsushita I.; Motomura H.; Seki E.; Kimura T.; Radiographic changes and factors associated with subsequent progression of damage in weight-bearing joints of patients with rheumatoid arthritis under TNF-blocking therapies\u2014three-year observational study. Mod Rheumatol  2017,27(4),570-575","journal-title":"Mod Rheumatol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/rheumatology\/key424","volume":"58","author":"Hawley S.","year":"2019","unstructured":"Hawley S.; Ali M.S.; Cordtz R.; Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: A matched cohort analysis of BSRBR-RA UK registry data. Rheumatology  2019,58(7),1168-1175","journal-title":"Rheumatology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5371\/hp.2024.36.4.273","volume":"36","author":"Takakubo Y.","year":"2024","unstructured":"Takakubo Y.; Sasaki K.; Ito J.; Oki H.; Ishii M.; Takagi M.; Biological agent and total hip arthroplasty in rheumatoid arthritis. Hip Pelvis  2024,36(4),273-280","journal-title":"Hip Pelvis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/rheumatology\/kead304","volume":"63","author":"Schreiner M.M.","year":"2024","unstructured":"Schreiner M.M.; Straub J.; Apprich S.; The influence of biological DMARDs on aseptic arthroplasty loosening: A retrospective cohort study. Rheumatology  2024,63(4),970-976","journal-title":"Rheumatology"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/acr.22596","volume":"67","author":"Asai S.","year":"2015","unstructured":"Asai S.; Kojima T.; Oguchi T.; Effects of concomitant methotrexate on large joint replacement in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: A multicenter retrospective cohort study in japan. Arthritis Care Res  2015,67(10),1363-1370","journal-title":"Arthritis Care Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"108484","DOI":"10.1016\/j.clim.2020.108484","volume":"217","author":"Fischer J.","year":"2020","unstructured":"Fischer J.; Dirks J.; Haase G.; IL-21+ CD4+ T helper cells co-expressing IFN-\u03b3 and TNF-\u03b1 accumulate in the joints of antinuclear antibody positive patients with juvenile idiopathic arthritis. Clin Immunol  2020,217,108484","journal-title":"Clin Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1122233","DOI":"10.3389\/fped.2023.1122233","volume":"11","author":"Zhang T.","year":"2023","unstructured":"Zhang T.; Huang S.; Guo Y.; Effectiveness of tumor necrosis factor inhibitors in children with enthesitis-related arthritis: A single-center retrospective analysis. Front Pediatr  2023,11,1122233","journal-title":"Front Pediatr"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jbspin.2008.03.008","volume":"76","author":"Sulpice M.","year":"2009","unstructured":"Sulpice M.; Deslandre C.J.; Quartier P.; Efficacy and safety of TNF\u03b1 antagonist therapy in patients with juvenile spondyloarthropathies. Joint Bone Spine  2009,76(1),24-27","journal-title":"Joint Bone Spine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jbspin.2014.03.006","volume":"81","author":"Remy A.","year":"2014","unstructured":"Remy A.; Combe B.; Repair of radiographic hip joint in juvenile rheumatoid arthritis patients treated with etanercept plus methotrexate. Joint Bone Spine  2014,81(5),447-449","journal-title":"Joint Bone Spine"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"Hunter C.A.","year":"2015","unstructured":"Hunter C.A.; Jones S.A.; IL-6 as a keystone cytokine in health and disease. Nat Immunol  2015,16(5),448-457","journal-title":"Nat Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"Scheller J.","year":"2011","unstructured":"Scheller J.; Chalaris A.; Schmidt-Arras D.; Rose-John S.; The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta Mol Cell Res  2011,1813(5),878-888","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000505099","volume":"98","author":"Uciechowski P.","year":"2020","unstructured":"Uciechowski P.; Dempke W.C.M.; Interleukin-6: A masterplayer in the cytokine network. Oncology  2020,98(3),131-137","journal-title":"Oncology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/annrheumdis-2011-200975","volume":"71","author":"Gottenberg J.E.","year":"2012","unstructured":"Gottenberg J.E.; Dayer J.M.; Lukas C.; Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: Results from the ESPOIR cohort. Ann Rheum Dis  2012,71(7),1243-1248","journal-title":"Ann Rheum Dis"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12891-015-0516-3","volume":"16","author":"Savio S.A.","year":"2015","unstructured":"Savio S.A.; Diaz M.A.C.; Capote C.A.; Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from Rheumatoid arthritis patients. BMC Musculoskelet Disord  2015,16(1),51","journal-title":"BMC Musculoskelet Disord"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.30158","volume":"63","author":"Kremer J.M.","year":"2011","unstructured":"Kremer J.M.; Blanco R.; Brzosko M.; Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu. Arthritis Rheum  2011,63(3),609-621","journal-title":"Arthritis Rheum"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","volume":"71","author":"Smolen J.S.","year":"2012","unstructured":"Smolen J.S.; Avila J.C.M.; Aletaha D.; Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: Disassociation of the link between inflammation and destruction. Ann Rheum Dis  2012,71(5),687-693","journal-title":"Ann Rheum Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3109\/s10165-012-0711-0","volume":"23","author":"Inaba Y.","year":"2013","unstructured":"Inaba Y.; Ozawa R.; Aoki C.; Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis. Mod Rheumatol  2013,23(4),667-673","journal-title":"Mod Rheumatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3899\/jrheum.130924","volume":"41","author":"Aoki C.","year":"2014","unstructured":"Aoki C.; Inaba Y.; Choe H.; Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis. J Rheumatol  2014,41(6),1171-1177","journal-title":"J Rheumatol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13075-016-1200-1","volume":"18","author":"Inman R.D.","year":"2016","unstructured":"Inman R.D.; Baraliakos X.; Hermann K.G.A.; Serum biomarkers and changes in clinical\/MRI evidence of golimumab-treated patients with ankylosing spondylitis: Results of the randomized, placebo-controlled GO-RAISE study. Arthritis Res Ther  2016,18(1),304","journal-title":"Arthritis Res Ther"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/annrheumdis-2013-204963","volume":"74","author":"Sieper J.","year":"2015","unstructured":"Sieper J.; Braun J.; Kay J.; Sarilumab for the treatment of ankylosing spondylitis: Results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN). Ann Rheum Dis  2015,74(6),1051-1057","journal-title":"Ann Rheum Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","volume":"167","author":"Koenders M.I.","year":"2005","unstructured":"Koenders M.I.; Lubberts E.; Oppers-Walgreen B.; Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol  2005,167(1),141-149","journal-title":"Am J Pathol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/rheumatology\/key375","volume":"58","author":"Braun J.","year":"2019","unstructured":"Braun J.; Baraliakos X.; Deodhar A.; Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology  2019,58(5),859-868","journal-title":"Rheumatology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"21094","DOI":"10.1038\/s41598-020-78204-6","volume":"10","author":"Kaaij M.H.","year":"2020","unstructured":"Kaaij M.H.; Helder B.; van Mens L.J.J.; van de Sande M.G.H.; Baeten D.L.P.; Tas S.W.; Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis. Sci Rep  2020,10(1),21094","journal-title":"Sci Rep"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/ard.2003.008458","volume":"63","author":"O\u2019 Gradaigh D.","year":"2004","unstructured":"O\u2019 Gradaigh D.; Ireland D.; Bord S.; Compston J.E.; Joint erosion in rheumatoid arthritis: Interactions between tumour necrosis factor \u03b1, interleukin 1, and receptor activator of nuclear factor \u03baB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis  2004,63(4),354-359","journal-title":"Ann Rheum Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/1529-0131(200005)43:5<1001:AID-ANR7>3.0.CO;2-P","volume":"43","author":"Jiang Y.","year":"2000","unstructured":"Jiang Y.; Genant H.K.; Watt I.; A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores. Arthritis Rheum  2000,43(5),1001-1009","journal-title":"Arthritis Rheum"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10141","volume":"46","author":"Cohen S.","year":"2002","unstructured":"Cohen S.; Hurd E.; Cush J.; Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin\u20101 receptor antagonist, in combination with methotrexate: Results of a twenty\u2010four-week, multicenter, randomized, double\u2010blind, placebo\u2010controlled trial. Arthritis Rheum  2002,46(3),614-624","journal-title":"Arthritis Rheum"},{"key":"ref=68","first-page":"2398","volume":"33","author":"Gartlehner G.","year":"2006","unstructured":"Gartlehner G.; Hansen R.A.; Jonas B.L.; Thieda P.; Lohr K.N.; The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis. J Rheumatol  2006,33(12),2398-2408","journal-title":"J Rheumatol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.reuma.2015.12.007","volume":"13","author":"Aguiar F.","year":"2017","unstructured":"Aguiar F.; Brito I.; Structural damage to the hip in systemic juvenile idiopathic arthritis: A case of regression with Anakinra. Reumatol Cl\u00edn  2017,13(2),118-119","journal-title":"Reumatol Cl\u00edn"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/jcm6090081","volume":"6","author":"Yago T.","year":"2017","unstructured":"Yago T.; Nanke Y.; Kawamoto M.; Kobashigawa T.; Yamanaka H.; Kotake S.; IL-23 and Th17 disease in inflammatory arthritis. J Clin Med  2017,6(9),81","journal-title":"J Clin Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"Sherlock J.P.","year":"2012","unstructured":"Sherlock J.P.; Joyce-Shaikh B.; Turner S.P.; IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4\u2212CD8\u2212 entheseal resident T cells. Nat Med  2012,18(7),1069-1076","journal-title":"Nat Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/art.34436","volume":"64","author":"Kavanaugh A.","year":"2012","unstructured":"Kavanaugh A.; van der Heijde D.; McInnes I.B.; Golimumab in psoriatic arthritis: One\u2010year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo\u2010controlled trial. Arthritis Rheum  2012,64(8),2504-2517","journal-title":"Arthritis Rheum"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"001149","DOI":"10.1136\/rmdopen-2019-001149","volume":"6","author":"Helliwell P.S.","year":"2020","unstructured":"Helliwell P.S.; Gladman D.D.; Chakravarty S.D.; Effects of ustekinumab on spondylitis-associated endpoints in TNFi-na\u00efve active psoriatic arthritis patients with physician-reported spondylitis: Pooled results from two phase 3, randomised, controlled trials. RMD Open  2020,6(1),001149","journal-title":"RMD Open"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jbspin.2012.06.016","volume":"80","author":"Fiocco U.","year":"2013","unstructured":"Fiocco U.; Sfriso P.; Oliviero F.; Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers. Joint Bone Spine  2013,80(2),165-170","journal-title":"Joint Bone Spine"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"R148","DOI":"10.1186\/ar3090","volume":"12","author":"Fiocco U.","year":"2010","unstructured":"Fiocco U.; Sfriso P.; Oliviero F.; Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-\u03b1 blockade in the knee joint. Arthritis Res Ther  2010,12(4),R148","journal-title":"Arthritis Res Ther"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/0394632015593220","volume":"29","author":"Carubbi F.","year":"2016","unstructured":"Carubbi F.; Zugaro L.; Cipriani P.; Safety and efficacy of intra-articular anti-tumor necrosis factor \u03b1 agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare. Int J Immunopathol Pharmacol  2016,29(2),252-266","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971396868251024105345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249332\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115733971396868251024105345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T07:04:04Z","timestamp":1788159844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249332\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115733971396868251024105345","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15733971396868"}}